BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31373759)

  • 1. Long noncoding RNA GAS5 silencing inhibits the expression of KCNQ3 by sponging miR-135a-5p to prevent the progression of epilepsy.
    Li BG; Wu WJ; Zheng HC; Yang HF; Zuo YX; Cui XP
    Kaohsiung J Med Sci; 2019 Sep; 35(9):527-534. PubMed ID: 31373759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of GAS5 represses the malignant progression of atherosclerosis through upregulation of miR-135a.
    Shen S; Zheng X; Zhu Z; Zhao S; Zhou Q; Song Z; Wang G; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109302. PubMed ID: 31545249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA GAS5 promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating the miR-135a-5p/FOXO1 pathway.
    Wang X; Zhao D; Zhu Y; Dong Y; Liu Y
    Mol Cell Endocrinol; 2019 Oct; 496():110534. PubMed ID: 31398367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA GAS5 regulates myocardial infarction by targeting the miR-525-5p/CALM2 axis.
    Zhang Y; Hou YM; Gao F; Xiao JW; Li CC; Tang Y
    J Cell Biochem; 2019 Nov; 120(11):18678-18688. PubMed ID: 31429119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA GAS5 exacerbates renal tubular epithelial fibrosis by acting as a competing endogenous RNA of miR-96-5p.
    Wang W; Jia YJ; Yang YL; Xue M; Zheng ZJ; Wang L; Xue YM
    Biomed Pharmacother; 2020 Jan; 121():109411. PubMed ID: 31810140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
    Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y
    Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxO1 Silencing Facilitates Neurological Function Recovery in Intracerebral Hemorrhage Mice via the lncRNA GAS5/miR-378a-5p/Hspa5 Axis.
    Wang B; Zhao X; Xiao L; Chen Y
    J Stroke Cerebrovasc Dis; 2022 Jul; 31(7):106443. PubMed ID: 35487009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA GAS5 Suppresses 3T3-L1 Cells Adipogenesis Through miR-21a-5p/PTEN Signal Pathway.
    Liu H; Li H; Jin L; Li G; Hu S; Ning C; Guo J; Shuai S; Li X; Li M
    DNA Cell Biol; 2018 Sep; 37(9):767-777. PubMed ID: 30020817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GAS5 inhibits the proliferation and invasion of ovarian clear cell carcinoma via the miR-31-5p/ARID1A axis.
    Zhang J; Yang ZM; Huang Y; Wang KN; Xie Y; Yang N
    Kaohsiung J Med Sci; 2021 Nov; 37(11):940-950. PubMed ID: 34414664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA GAS5 regulates human B lymphocytic leukaemia tumourigenesis and metastasis by sponging miR-222.
    Jing Z; Gao L; Wang H; Chen J; Nie B; Hong Q
    Cancer Biomark; 2019; 26(3):385-392. PubMed ID: 31594210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p.
    Han Y; Wu N; Xia F; Liu S; Jia D
    Int J Mol Med; 2020 Mar; 45(3):858-872. PubMed ID: 31985016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA growth arrest specific transcript 5 inhibits the growth of pituitary neuroendocrine tumors via miR-27a-5p/cylindromatosis axis.
    Wang H; Wu B; Wang H; Jiang C; Liu Z
    Bioengineered; 2022 Apr; 13(4):10274-10286. PubMed ID: 35435104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy.
    Wan Y; Yang ZQ
    Cell Cycle; 2020 Feb; 19(4):419-431. PubMed ID: 31948324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA GAS5 inhibits cell proliferation and fibrosis in diabetic nephropathy by sponging miR-221 and modulating SIRT1 expression.
    Ge X; Xu B; Xu W; Xia L; Xu Z; Shen L; Peng W; Huang S
    Aging (Albany NY); 2019 Oct; 11(20):8745-8759. PubMed ID: 31631065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p.
    Liu Q; Yu W; Zhu S; Cheng K; Xu H; Lv Y; Long X; Ma L; Huang J; Sun S; Wang K
    J Cell Physiol; 2018 Jan; 234(1):757-768. PubMed ID: 30078184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GAS5 promotes abdominal aortic aneurysm formation through regulating the miR-185-5p/ADCY7 axis.
    Wang Y; Zhai S; Xing J; He Y; Li T
    Anticancer Drugs; 2022 Mar; 33(3):225-234. PubMed ID: 34974476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis.
    Luo L; Wang Y; Hu P; Wu J
    Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA GAS5 promotes epilepsy progression through the epigenetic repression of miR-219, in turn affecting CaMKIIγ/NMDAR pathway.
    Zhao CS; Liu DX; Fan YH; Wu JK
    J Neurogenet; 2022 Mar; 36(1):32-42. PubMed ID: 35642561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAS5 knockdown suppresses inflammation and oxidative stress induced by oxidized low-density lipoprotein in macrophages by sponging miR-135a.
    Zhang Y; Lu X; Yang M; Shangguan J; Yin Y
    Mol Cell Biochem; 2021 Feb; 476(2):949-957. PubMed ID: 33128668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.